Dexter: Resurrection has confirmed the returns of a few original characters in the new sequel, fixing a complaint from New ...
Sanofi's phase 3 study shows Sarclisa SC matches IV formulation in efficacy for relapsed myeloma. Regulatory submissions are planned for 2025.
I missed Creative Assembly's final post of 2024, but it does make it sound very much like we're getting a Total War: Warhammer 40,000 announcement soon.
Dexter: Original Sin got a chance to fix a plot hole that Dexter: New Blood created three years ago, and the prequel show ended up ignoring it.